RxDoctor Payments Data

Brownhilda Tanyi

Acute Care · Largo, MDNPI 1194494534

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 111 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 13.4% — the pattern of someone who eats at a lot of different presentations. Among acute care clinicians in MD with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$2,435in general payments, 2019–2025

Across 111 payments — averaging $21.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Lilly USA, LLC$326
  • GSK$311
  • Bayer$279
  • Novo Nordisk$243
  • AstraZeneca$235
  • Amgen$190
  • plus $850 from 17 others

What the payments were for

  • Food & beverage$2,435100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,435 in reported general payments places this provider in the 90th percentile of 502 acute care providers in Maryland.

See all acute care providers in Maryland

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide22$48,473
TrulicityDulaglutide24$42,684
MounjaroTirzepatide12$24,479
JardianceEmpagliflozin17$20,274
FarxigaDapagliflozin Propanediol12$19,247
JanuviaSitagliptin Phosphate15$18,761
EliquisApixaban14$9,528
Rosuvastatin Calcium37$1,060
Nifedipine ErNifedipine19$677
Azelastine Hcl14$676
Potassium Chloride23$539
Metoprolol Succinate31$538
Atorvastatin Calcium52$443
Labetalol Hcl17$441
Pregabalin12$409

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity, Mounjaro$326$67,16336 claims
Novo NordiskOzempic$243$48,47322 claims
Boehringer IngelheimJardiance$61$20,27417 claims
AstraZenecaFarxiga$235$19,24712 claims
PfizerEliquis$28$9,52814 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 502 acute care providers in Maryland.

Other acute care in Largo

See the full list for Maryland

Where these figures come from

Is this you, or does something look wrong? →